| Literature DB >> 26468376 |
S J Moug1, K McCarthy2, J Coode-Bate3, M J Stechman4, J Hewitt5.
Abstract
BACKGROUND: Laparoscopic surgery is being increasingly offered to the older person.Entities:
Keywords: Laparoscopic surgery; Older people; Systematic review
Year: 2015 PMID: 26468376 PMCID: PMC4572399 DOI: 10.1016/j.amsu.2015.08.002
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Flow diagram of systematic review of laparoscopic versus open surgery for colorectal cancer, including the reasons for exclusion.
Description of randomised controlled trials comparing laparoscopic versus open colorectal surgery.
| Date randomised | Date published | Number of centres | Largest participants number | |
|---|---|---|---|---|
| ALCCaS | January 1998 | 2000; 2012 | 31 | 592 |
| CLASICC | July 1996 | 2005; 2007; 2010; 2013 | 27 | 794 |
| Leung KL et al. | September 1993 | 2004 | 2 | 403 |
| Lacy AM et al. | November 1993 | 2002 | 1 | 219 |
| COST | August 1994 | 2002; 2004; 2007 | 48 | 872 |
| COLOR I | March 1997 | 2005, 2009 | 30 | 1076 |
| COLOR II | January 2004 | 2013 | 30 | 1044 |
| Braga M et al. | February 2000 | 2002; 2004; 2005 (a,b); 2007 (a,b); 2010 | 1 | 391 |
Summary: only 7 different trial group/s.
Distribution of participants' age for the selected RCTs.
| Laparoscopic arm | Open arm | Sub-analysis on age | |
|---|---|---|---|
| ALCCaS | 71.1 (35.9–94.2) | 69.4 (34.3–100.1) | Yes |
| CLASICC | 69 (11) | 69 (11) | Yes |
| Leung KL et al. | 67.1 (11.7) | 66.5 (12.3) | No |
| Lacy AM et al. | 68 (12) | 71 (11) | No |
| COST | No | ||
| COLOR I | 71 (27–92) | 71 (31–95) | No |
| COLOR II | 66.8 (34–93) | 65.8 (31–90) | No |
| Braga M et al. | 63.7 (13.8) | 65.1 (12.6) | No |
All ages are mean ± SD or range as appropriate.
Median age quoted.
Short-term outcomes after surgery in selected RCTs.
| Laparoscopic arm | Open arm | P value | ||
|---|---|---|---|---|
| Conversion rate (%) | ALCCaS | 14.6% | ||
| CLASICC | 29% | |||
| Leung KL et al. | 23.2% | |||
| Lacy AM et al. | Not documented | |||
| COST | 21% | |||
| COLOR I | 17% | |||
| COLOR II | 16% | |||
| Braga M et al. | 5.1% | |||
| Length of hospital stay (days) | ALCCaS | 7 (1–55) | 8 (4–59) | 0.0001 |
| CLASICC | 9 (7–13)* | 11 (8–15)* | n/a | |
| Leung KL et al. | 8.2 (2–99) | 8.7 (3–39) | >0.05 | |
| Lacy AM et al. | 5.2 (2.1)* | 7.9 (9.3)* | 0.005 | |
| COST | 5.6 (0.26) | 6.4 (0.23) | <0.001 | |
| COLOR I | 8.2 (6.6)* | 9.3 (7.3)* | <0.0001 | |
| COLOR II | 8 (6–13) | 9 (7–14) | 0.036 | |
| Braga M et al. | 9.4 (4) | 12.7 (5–29) | 0.002 | |
| Post-operative morbidity (%)ˆ | ALCCaS | 37.8% | 45.3% | 0.062 |
| CLASICC | 29% | 31% | 0.78 | |
| Leung KL et al. | 24% | 26% | <0.001 | |
| Lacy AM et al. | 11% | 28.7% | 0.001 | |
| COST | 20% | 21% | 0.64 | |
| COLOR I | 21% | 20% | 0.90 | |
| COLOR II | 40% | 37% | 0.424 | |
| Braga M et al. | 20.6% | 38.3% | 0.003 | |
| 28 Day post-operative mortality (%)¶ | ALCCaS (in hospital death) | 1.4% | 0.7% | 0.448 |
| CLASICC | 4% | 5% | 0.57 | |
| Leung KL et al.** | 0.6% | 2.4% | 0.97 | |
| Lacy AM et al. | 1% | 3% | 0.19 | |
| COST | 1% | <1% | 0.40 | |
| COLOR I*** | 1% | 2% | 0.47 | |
| COLOR II*** | 1% | 2% | 0.409 | |
| Braga M et al. | <1% | 0 | n/a |
All lengths of hospital stay are median (range) unless *mean ± SD. ¶Actual percentages not documented so calculated from projected figures. ˆThis varied between studies but included infection, would or anastomotic failure, renal or liver failure, ileus and return to theatre **no data for time period ***30 day mortality. In study groups where different outcomes are published in different papers, the figures are taken from those papers that had short-term outcomes as their primary aim.
Long-term outcomes after surgery in selected RCTs (n = 6).
| Laparoscopic arm | Open arm | P value | ||
|---|---|---|---|---|
| Follow up (months) | ALCCaS | 62.4 (1–135) | ||
| CLASICC | 62.9 (22.0–92.8) | |||
| Leung KL et al. | 52.7 (38.9)¶ | 49.2 (35.4)¶ | >0.05 | |
| Lacy AM et al. | 44 (27–85) | 43 (27–85) | ||
| COST | 51 | |||
| COLOR I | 53 (0.03–60) | |||
| Braga M et al.§ | 73 (48–106) | |||
| Port site/wound recurrences | ALCCaS | |||
| CLASICC | 10 | 2 | >0.05 | |
| Leung KL et al. | 0 | 0 | ||
| Lacy AM et al. | 1 | 0 | ||
| COST | 2 (0.5%) | 1 (0.2%) | 0.58 | |
| COLOR I | 1.3% | 0.4% | 0.09 | |
| Braga M et al.§ | 0 | |||
| Overall survival | ALCCaS | 77.7% | 76.0% | 0.64 |
| CLASICC | 82.7 (69.1–94.8)♮ | 78.3 (65.8–106.6)♮ | 0.08 | |
| Leung KL et al.* | 76.1% (3.7%) | 72.9% (4.0) | 0.61 | |
| Lacy AM et al.¶ | 80% | 70% | 0.16 | |
| COST | 76/435♯ | 84/428♯ | 0.51 | |
| COLOR I⌃ | 81.8% (78.4–85.1) | 84.2% (81.1–87.3) | 0.45 | |
| Braga M et al.§ | 72% | 66% | 0.321 | |
COLOR II has been removed from these tables as no long-term follow up.
Missing values are due to missing values in the published work.
All follow up times are median (range) unless ¶median ± interquartile range.
Disease free and overall survivals are documented as 5 year survival (±Standard Error) unless ♮ median (range) or *mean ± SD or ♯number of patients with recurrence (or death)/total number of patients in that group. ¶Actual percentages not documented so calculated from figures – see text for discussion on cancer-related survival. ⌃3 year survival rates (95% Confidence intervals).
§Taken from Braga et al. 2010 as the only paper in this series to document long term outcomes – this paper only included left sided colonic resections.
Participant inclusion and exclusion criteria of the selected RCTs.
| Inclusion criteria | Exclusion criteria | Jadad score | |
|---|---|---|---|
| ALCCaS | Colon | Transverse colon cancers; rectal cancers; T4, Stage IV; intestinal obstruction; ASA 4/5; BMI > 35 | 3 |
| CLASICC | Colon and rectum | Transverse colon cancers: unsuitable for GA. | 3 |
| Leung KL et al. | Recto-sigmoid cancers only | Low rectal cancers (<5 cm); T4 disease; Stage IV disease; intestinal obstruction | 3 |
| Lacy AM et al. | Colon | Transverse colon cancers; rectal cancers; T4; Stage IV; previous colonic surgery; ASA 4/5; intestinal obstruction | 2 |
| COST | Colon | Transverse colon cancers; rectal cancers; T4; Stage IV; intestinal obstruction; adhesions | 3 |
| COLOR | I – colon | Transverse colon cancers; T4; Stage IV; intestinal obstruction; BMI > 30 (COLOR I only). | 3 |
| Braga M et al. | Colon and rectum | Transverse colon cancers; T4 stage IV; ASA 4/5 | 3 |
COLOR II excluded T3 rectal cancers within 2 mm from endopelvic fascia.
A total of 7 studies here analysing various types of surgical resection, but the exclusion criteria listed here is common to all.